De-Risk Your Early Phase Programs
Lipid based drug delivery systems (LBDDS) are the most studied and understood bioavailability enhancing solutions
Innovative OTC Remedies for the Seasonal Flu Epidemic
We will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms.
Is Lipid Based Formulation Best for Your Molecule?
Watch this webinar to learn the key considerations for evaluating available technologies to find the most suitable bioavailability solution.
Using Lipid Based Delivery For Early Phase Development
Lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules
The Truths and Myths of LBDDS
Clarifying the myths surrounding LBDSS which may make drug developers consider it in parallel to other formulation approaches
Overcome Bioavailability Challenges with Lipid Drug Delivery
How to apply lipid based formulation and encapsulate in softgel capsules for a poorly soluble molecule.
Optimizing Clinical Outcomes for Challenging Molecules
How lipid-based drug delivery systems (LBDDS) can be used as a bioavailability enhancing technology.
The Challenges in Developing Therapeutic Cannabis
Development of Cannabis- based drugs can offer a consistent, reliable dose with minimal side effects.
Pediatric Drug Delivery Challenges and Solutions
Key development challenges and promising technologies for delivering pediatric formulations.
Lipid Workshop Part 2: Expanding Lipid Formulation Platform
Latest softgel technology for targeted and controlled delivery of challenging molecules.
Lipid Workshop Part 1: Early Development With Lipids
Softgel technology for early development to achieve successful formulation and patient outcomes.
Softgel: Shapes and Sizes
Softgel technology has been increasingly applied across a wide range of applications including prescription medicines, consumer health, vitamins & mineral supplements and cosmetics.
The Soft Side of Drug Delivery
Discover an innovative way to deliver challenging and poorly soluble compounds.
OptiShell™ Technology for the OTC Market
Innovative solution for overcoming encapsulation challenges for OTC products.
LBDDS to Bring Poorly Soluble Drugs to Market
Address compounds early on in the development process to reduce costs & attrition rates.
Overcome Formulation Challenges & Gain Customer Acceptance
Enhance bioavailability, deliver liquid APIs & more with softgel technology.
Softgel Technologies to Deliver Poorly Soluble Molecules
Expedite the development pathway for early phase compounds and enhance bioavailability.
Catalent Innovations, Trends and New Technologies
Boost bioavailability, improve ease & route of administration, and increase patient compliance.
Enteric Coated Softgels for Consumer Products
Improve product performance & enhance consumer experience with enteric coating.
Softgel Capsules Low Batch Size Optimize in cGMP Labs
Handle small amounts of API or formulation at the early stages of development.
Optimization of Type I & II Lipid Based Drug Delivery System
Limit individual variability of type I & II systems with adequate choice of composition.
Solutions for Challenging Compounds Using Softgel Innovation
Improve compatibility with wider range of excipients to enhance bioavailability & stability.
The Versatility of Softgel Technology
Optimize manufacturing parameters like lower processing temperature & thinner softgel shell.
New Approaches for Macromolecule Oral Delivery
The toolkit of technologies based upon lipid-based drug delivery systems.
OptiGel Mini Technology
Deliver higher API concentrations in smaller capsules for patient benefits.
AAPS 2014 with Pharmaceutical Outsourcing
OptiPact™ Technology, capabilities for Orphan Drugs & Catalent’s factors of differentiation.
OptiGel Bio Enables Delivery of Synthetic Oligosaccharides
Macromolecules can potentially be converted from injectable to oral drug delivery.
Lipid-Based Delivery of Peptide Therapeutics
An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates.
Conversion from LFHS to RP Scherer Softgel Capsules
RP Scherer Technology can improve timelines and commercialization potential.
OptiShell® Technology Capsule Innovations
New shell and hot-filling that are highly viscous or semi-solid at room temperature